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1ABSTRACT
Value of Amide Proton Transfer Imaging in Correlation with 
Histopathological Grades of Adult Diffuse Gliomas : Comparison and 
Incremental Value with Dynamic Susceptibility Contrast-Enhanced MRI 
and Diffusion Weighted Imaging
Yoon Seong Choi
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Seung-Koo Lee)
Purpose: Amide proton transfer (APT), a subtype of chemical exchange 
saturation transfer, is a novel technique to detect concentration of 
endogenous peptide or protein without exogenous contrast agent 
administration. We investigated the difference in APT values according
to histopathological grades, and compared the diagnostic value of APT 
with relative cerebral blood volume (rCBV) from dynamic susceptibility 
contrast-enhanced (DSC) MRI and apparent diffusion coefficient (ADC) 
from diffusion weighted imaging (DWI) for histopathological grades in 
adult diffuse gliomas. We also investigated the incremental value of APT 
over ADC and rCBV for discriminating high grade and low grade 
gliomas.
Material and Methods: The study cohort consisted of 39 adult patients 
with histopathologically proven diffuse glioma who underwent 
preoperative APT imaging, with 34 patients available for preoperative 
DSC MRI and DWI. Regions of interest were obtained from circles 
manually placed at the area with high signal in APT and rCBV map, and 
2low signal in ADC map. APT signal was compared according to WHO 
grade or low vs high grade of glioma. Diagnostic ability to discriminate 
high grade glioma from low grade glioma were compared between APT, 
ADC, and rCBV by using Receiver operative characteristic (ROC) 
analysis, and incremental diagnostic value of APT over ADC and rCBV 
were assessed by using integrated discrimination index. Also, the 
correlation between APT values and Ki-67 labeling index (LI) was 
assessed by linear regression.
Results: The APT SI values were 0.82 ± 0.36%  in grade II gliomas, 
1.73 ± 0.86% in grade III, and 2.62 ± 0.78% in grade IV gliomas, which 
showed significant difference between grade II and III (p=0.018), III and 
IV (p = 0.010), as well as II and IV (p < 0.001). The diagnostic value to 
discriminate between high and low grade glioma was not significantly 
different between APT, ADC and rCBV, with area under the ROC curve 
(AUC) of 0.890, 0.917, and 0.947, respectively. (p > 0.05 for each 
comparison) Incremental diagnostic value of APT was significant over 
ADC (p = 0.003), and not significant over rCBV (p=0.066). APT signals 
were significantly correlated with Ki-67 LI. (p=0.001, R2 = 0.26)
Conclusion: APT imaging can be useful, and have incremental value over 
ADC for predicting the histopathological grades of adult diffuse gliomas. 
APT SI can be correlated with Ki-67 LI.
----------------------------------------------------------------------------------------
Key words : Glioma, Grade, Magnetic resonance imaging, amide proton 
transfer, chemical exchange saturation transfer
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Incremental Value with Dynamic Susceptibility Contrast-Enhanced MRI 
and Diffusion Weighted Imaging
Yoon Seong Choi
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Seung-Koo Lee)
I. INTRODUCTION
Glioma is the most common brain tumor and glioblastoma is the most 
malignant brain tumor in adults. 1,2 Discrimination between high and low grade 
glioma is of clinical relevance, because prognosis and treatment strategies are 
substantially different according to glioma grades.3 Surgical resection followed 
by concurrent chemoradiation with temozolomide is standard treatment for high 
grade glioma,3 and undergrading of high grade glioma as low grade glioma can 
lead to insufficient and less aggressive treatment. 
The gold standard for glioma grades and molecular or genetic profiles is 
surgical sampling which takes invasive procedure and risk of sampling from 
suboptimal site and undergrading of tumor, considering intratumoral 
heterogeneity of high grade gliomas. Thus, advanced MR techniques such as 
dynamic susceptibility contrast-enhanced (DSC) MRI and diffusion weighted 
imaging (DWI) have been utilized as noninvasive imaging biomarker. Many 
previous studies investigated the relative cerebral blood volume (rCBV) from 
DSC MRI and apparent diffusion coefficient (ADC) from DWI in correlation 
with glioma grade, genetic profile or prognosis, however with some conflicting 
results.4–11
Amide proton transfer (APT) imaging is a subtype of chemical exchange 
4saturation transfer (CEST) imaging that reflects concentration of endogenous 
peptides or proteins without contrast agent administration. 12–14 In APT imaging, 
a pulse with radiofrequency of amide (-NH) proton (3.5ppm) in peptides and
proteins selectively saturates the signal from amide protons and these saturated 
amide protons exchange with protons from bulk water, consequently reducing 
the signal at 3.5ppm from bulk water. Thus, peptides and protein concentration 
can be indirectly assessed from calculating the asymmetric signal decrease from 
bulk water at 3.5ppm, although other factors such as pH or temperature can also 
affect the APT signal intensity (SI). 12–16 Several previous studies investigated 
APT imaging in brain tumor. Previous studies reported that APT SI in brain 
tumor was mainly attributed to protein concentration, 17 and APT SI was higher 
in brain tumor than normal tissue. 18 Togao et al.19  obtained APT images from 
one dominant section of gliomas and reported that APT imaging can be useful 
for predicting histopathological grade of glioma. However, protocol of APT 
imaging needs to be optimized and validated in clinical setting and given that
other advanced MR techniques such as DSC MRI or DWI is available in 
clinical setting, compatibility and incremental value of APT with ADC or rCBV 
for predicting glioma grades are of clinical importance, which has not been 
elucidated.
The purpose of this study was to investigate the diagnostic value of APT 
compared with those of ADC and rCBV, and incremental diagnostic value of 
APT over ADC and rCBV for predicting histopathological grade in diffuse 
gliomas in adults, with clinically optimized APT imaging protocols. We also 
investigated the correlation between APT SI and Ki-67 labeling index (LI).
II. MATERIALS AND METHODS
1. Protocol optimization with phantom experiment
Considering that protein concentration, pH, and radiofrequency (RF) saturation 
power and duration, RF saturation power was pivotal for  APT imaging 
5protocol optimization, which was optimized to visualize the signal difference 
according to various protein concentrations so that the signal differences 
between brain tumor and normal tissue are well visualized. Phantom experiment 
for protocol optimization was performed with two sequences : three 
dimensional fast field echo (3D FFE) and three dimensional gradient and spine 
echo (3D GRASE) as described elsewhere. 20–23 The first experiment was 
conducted with 3D FFE and 4 phantoms with 0% and 5% bovine serum 
albumin (BSA) at pH 6.5 and 7.4, respectively. Each phantom was scanned with 
varied RF powers of 0.5µT, 1 2µT, and 3µT with RF durations of 35msec, 
70msec and 105 msec, thus 4 phantoms x 4 RF powers x 3 RF durations = 48 
times of APT imaging were performed. In the second experiment, a phantom 
with more variable BSA concentration and pH, consisting of 2%, 4%, 8% and 
16% BSA at pH 7.4, and pH 6, 6.5, 7, and pH 7.4 a 16% BSA, as shown in 
Figure 1, was scanned with both 3D FFE and GRASE sequences with RF 
powers of 1µT, 2µT, 3µT and 4µT and fixed RF durations of 35msec for FFE 
and 200ms for GRASE sequence. 
Fig. 1. A phantom with variable BSA concentrations and pH for protocol 
optimization
62. Patients
The cohort of this study consisted of thirty-nine consecutive adult patients with 
histopathologically proven diffuse glioma who underwent preoperative MRI 
including APT imaging from Nov, 2014 to June, 2015, with thirty-four patients 
among them available for preoperative DWI and DSC MRI. The mean age of 
cohort was 47.2 ± 16.8 years old and male to female ratio was 21:18. The 
interval from APT imaging, DWI and DSC MRI to operation was 1.2 ± 0.4 days. 
3. Image acquisition
MRI studies were performed using a 3T system (Achieva, Philips Healthcare, 
Netherland, Best) and 32 channel receive head coil with transmit body coil. 
APT-weighted imaging was acquired using three-dimensional (3D) gradient-
and spin-echo (GRASE) approach, 23 with the following parameters : voxel size, 
2.2ⅹ2.2 mm; slice thickness, 4.4 mm; repetition time/echo time, 3000 msec/17 
msec; TSE factor, 22; EPI factor, 7; and number of slices, 15 to cover entire 
tumor volume. By 4 repetitions at ±3.5 ppm with six saturation frequency 
offsets (±3.0, ±3.5 and ±4.0 ppm), sufficient signal-to-noise ratio(SNR) could 
be achieved within clinical time frame. APT imaging was conducted with RF 
saturation amplitude of 2 µT and total duration of 800ms consisting of four 
block pulsed saturation scheme. Water frequency shift due to field 
inhomogeneity was measured in a separate scan using the water saturation shift 
referencing method 24 with 21 offset frequencies ranging from -1.25 ppm to 
1.25 ppm at a step of 0.125 ppm (16 Hz) with one reference scan without 
saturation RF pulse resulting in full Z-spectrum within the offset range. This 
scan was acquired with repetition time/echo time of 1250 msec/17 msec and RF 
saturation amplitude of 0.5 µT with total duration of 400 ms consisting two 
block pulsed saturation scheme and the same imaging parameters as used in 
APT imaging. Both the APT and water saturation shift referencing scans were 
performed prior to contrast-enhanced T1-weigthed scan. Total acquisition time 
7was 7 min 36 sec for both water saturation shift referencing and APT scans.
Other conventional MR imaging sequences included T2-weighted turbo spin-
echo imaging, FLAIR turbo spin-echo imaging, and contrast-enhanced T1-
weighted gradient-echo imaging. Transverse T2-weighted turbo spin-echo 
images were obtained with the following parameters: repetition time /echo time, 
4629 msec/80 msec; number of slices, 90; voxel size, 0.98ⅹ1.02; slice 
thickness, 2.0 mm; scan time, 4 minutes 19 seconds. Transverse fluid attenuated 
inversion recovery (FLAIR) turbo spin-echo images were obtained with the 
following parameters: repetition time /echo time /inversion time, 11000 
msec/125 msec/2800 msec; number of slices, 100; voxel size, 0.98 ⅹ1.05; 
slice thickness, 2.0 mm, scan time, 8 minutes 48 seconds. Transverse 
gadolinium-enhanced T1-weighted gradient-echo images were acquired with 
the following parameters: repetition time/echo time, 2000 msec/1000 msec; 
number of slices, 90; voxel size, 0.98 x 0.79; slice thickness, 2.0 mm; scan time, 
13 minutes 12 seconds.
4. Image postprocessing analysis.
After water frequency shift correction, magnetization transfer ratio asymmetry 
(MTRasym) values at ±3.5ppm with respect to the water frequency, so called 
APT-weighted SI values were calculated 15,16 :
MTR    (+3.5ppm) =
S   (−3.5ppm)− S   (+3.5ppm)
S0
where S0 and Ssat(∆ω) are MRI signal without and with saturation RF pulse at 
offset frequency of ∆ω at downfield (+∆ω) and upfield (-∆ω) from water center 
frequency. All postprocessing of APT images was performed with Matlab 
(MathWorks, Natick, MA). The full the water saturation shift referencing Z-
spectrum was then fitted to a 12th order polynomial at each voxel, and the 
lowest signal in the fit after  interpolation at higher spectral resolution (1Hz) 
was assumed to be an actual water resonance frequency resulting in a water 
8center frequency offset at a corresponding voxel. The acquired APT data were 
organized according to the offsets, and the saturation images with the same 
offsets were averaged. The data for offsets (+4, +3.5, +3 ppm) and (-3, -3.5, -4 
ppm) for each voxel were interpolated to 385 points over a frequency offset 
range from +5 to+2 ppm and -2 to -5 ppm, respectively, and shifted using the 
fitted water saturation shift referencing central frequency offset at the same 
voxel. Based on the shift-corrected data, the parameter map of APT SI was 
calculated using an MTR asymmetry at ±3.5 ppm. 
Single or multiple circular regions of interest (ROIs) were placed manually on 
the areas with high SI on APT and rCBV maps, and areas with low SI on ADC 
map, that corresponds to solid enhancing portion on T1-weighted images, in 
case of presence of enhancement, or non-enhancing solid portion avoiding 
cystic or necrotic portion on T2-weighted images in case of non-enhancing 
tumors. The mean values from the ROIs on APT, ADC, and rCBV maps were 
analyzed in statistical analysis, and rCBV values were normalized to the SI of 
contralateral normal appearing white matter. The size of an ROI at each lesion 
ranged from 180.5 mm2 to 492.8 mm2. 
5. Pathological evaluation
The pathological diagnosis with glioma grade, and Ki-67 labelling index (LI)
were determined from specimen of surgical sampling. WHO grades of gliomas 
were determined histopathologically by an experienced neuropathologist. The 
Ki-67 LI was determined based on the fields with the highest number of Ki-67-
labeled cells through a generalized survey, and the percentage of positive cells 
was counted among approximately 1000 tumor cells.
6. Statistical analysis
Statistical analyses were performed with using R for Windows version 3.0.2 
(R Foundation for Statistical Computing, Nashville, TN, USA). For 39 
9patients from the entire cohort, APT SI was compared according to WHO grade 
(II, III or IV) by using one-way analysis of variance (ANOVA) and post hoc 
comparison with Bonferroni correction. For 34 patients who underwent 
preoperative DWI and DSC MRI, APT SI, ADC and rCBV values were 
compared between low (WHO grade II) and high grade (WHO grade III or IV) 
of glioma, using Student t-test according to result of Shapiro-Wilk test for 
normal distribution. Diagnostic ability of APT, ADC and rCBV values to 
discriminate high grade glioma from low grade glioma were assessed and 
compared by using Receiver operative characteristic (ROC) analysis and the 
method by DeLong. 25 Robustness of ROC analysis was confirmed by 
bootstrapping with 1000 replication and bias-corrected 95% confidential 
interval for area under the ROC curve (AUC). Incremental diagnostic value of 
APT over ADC and rCBV were assessed by calculating integrated 
discrimination improvement (IDI) index described by Pencina et al. 26 as 
follows : integrated discrimination improvement = (ISnew – ISold) – (IPnew – IPold), 
where “new” refers to a model containing a new diagnostic tool of interest as 
APT in our study, in addition to conventional risk predictors, “old” pertains to 
the model containing only the conventional predictors as ADC and rCBV in our 
study, and IS and IP are the integrals of sensitivity and (1 – specificity), 
respectively. For 39 patients from the entire cohort, the correlation between 
APT values and Ki-67 LI was assessed using simple linear regression. P value
<0.05 was considered statistically significant.
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III. RESULTS
1. Protocol optimization with phantom experiments
Figure 2 shows result of the first phantom experiment conducted with 4 
phantoms each with 0% and 4% BSA at pH 7.4 and pH 6.5. APT SI of 4% BSA 
phantom increased along with increased RF power and duration, regardless of 
pH, whereas APT SI of 0% BSA phantom did not change according to RF 
power, implicating that APT SI is attributed to protein concentration. No 
significant difference was found in APT SI according to pH change. 
Fig. 2. Results of experiments with phantoms with 0% and 4% BSA at pH 7.4 
and pH 6.5, and varied RF powers (0.5, 1, 2, and 3µT) and RF durations (35, 70, 
and 105msec).
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Figure 3 shows the result of the second experiment conducted with 3D FFE and 
GRASE, and a phantom with 2%, 4%, 8%, 16% BSA at pH 7.4 and pH 6, pH 
6.5, pH 7, pH 7.4 at 16% BSA, as shown in Figure 1. In experiment with 3D 
GRASE sequence, APT SI obtained with 1µT RF power did not show the 
difference in BSA concentration, whereas APT SI obtained with 2µT, 3µT and 
4µT RF power increased along with increased BSA concentration. In 
experiment with 3D FFE sequence, APT SI obtained with 1µT and 2µT RF 
power were not correlated with BSA concentration, and APT SI with 1 µT RF 
power showed unexpected negative values. APT SI obtained with 3µT and 4µT 
RF power increased along with increased BSA concentration. Considering 
clinical feasibility and other previous reports, 3D GRASE sequence with RF 
power of 2µT, the minimum RF power with which APT SI was correlated with 
BSA concentration, and with RF duration of 200msec was chosen for patient 
scan in clinical setting.
12
13
14
Fig. 3. Results of experiments with 3D GRASE (A-D) and FFE (E-H) 
sequences, and a phantom with 2%, 4%, 8%, 16% BSA at pH 7.4 and pH 6, pH 
6.5, pH 7, and pH 7.4 at 416% BSA.
2. Patients
Patient histologic and genetic characteristics are summarized in Table 1. The 39 
patients consisted of 12 patients with grade II, 9 patients with grade III, and 18 
patients with grade IV gliomas. 34 out of 39 patients underwent preoperative 
DWI and DSC MRI in addition to APT imaging.
15
Table 1. Histologic and molecular characteristics of the study cohort (n=39)
Histology Number Ki-67 LI
Grade II (n=12) 3.6 ± 2.2 
Astrocytoma 5
Oligodendroglioma 2
Oligoastrocytoma 5
Grade III (n=9) 11.9 ± 9.1 
Anaplastic astrocytoma 2
Anaplastic oligodendroglioma 1
Anaplastic oligoastrocytoma 6
Grade IV (n=18) 29.3 ± 29.5 
Glioblastoma 14
Glioblastoma with 
oligodendroglial component
2
Gliosarcoma 2
3. Difference of APT SI according to glioma grades
Difference of APT SI according to glioma grades are summarized in Table 2 
and shown in Figure 3 . The APT SI values were higher in higher glioma grade, 
which were 0.82 ± 0.36 % in grade II gliomas, 1.73 ± 0.86 %  in grade III, and 
2.62 ± 0.78 % in grade IV gliomas, showing significant difference between 
grade II and III (p = 0.018), III and IV (p = 0.010), as well as II and IV (p < 
0.001).
Table 2. Differences in APT SI according to WHO grades. (n=39).
APT SI P value a
II 0.82 ± 0.37 -
III 1.73 ± 0.86 -
IV 2.63 ± 0.78 -
II vs III - 0.018 
II vs IV - <0.001
III vs IV - 0.010 
a posthoc pairwise comparision with bonferroni 
correction after ANOVA
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Fig. 4. Difference of APT signal intensity according to glioma grades.
4. Comparison of diagnostic value between APT, ADC and rCBV for 
glioma grading
Difference of APT, ADC, and rCBV values between low and high grade 
gliomas are summarized in Table 3 and depicted in Figure 4. APT and rCBV 
values were higher and ADC values were lower in high grade glioma than in 
low grade glioma with staitistical significance. (p < 0.001 for all) 
Results from ROC analysis for discriminating high grade from low grade 
glioma is summarized in Table 4 and depicted in Figure 5. In ROC analysis, 
APT, ADC and rCBV values showed excellent diagnostic performance with 
AUC of 0.890, 0.917, and 0.947, respectively. Although AUC of APT was 
lower than those of ADC and rCBV, no statistical significance was found 
among the diagnostic value of APT, ADC and rCBV, implicating compatibility 
of APT as a diagnostic tool for glioma grades. Representative images of APT SI, 
17
ADC, and rCBV parameter maps from low and high grade gliomas are depicted 
in figure 6 and 7.
Table 3. Differences in APT, rCBV and ADC values between high- and low-
grade giomas (n=34)
Low grade glioma High grade glioma P value a
APT (%) 0.82 ± 0.37 2.33 ± 0.90 <0.001
ADC 
(10-6 mm3/sec)
1580.3 ± 284.5 962.5 ± 353.6 <0.001
rCBV 1.7 ± 2.3 8.6 ± 4.9 <0.001
a calculated from Student t-test
Fig. 5. Differences of APT, ADC and rCBV values between low and high grade 
gliomas.
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Table 4. ROC analysis of APT, rCBV and ADC to discriminate high- and low-
grade gliomas. (n=34)
AUC (95% CIa) Cutoff SensitivitySpecificityAccuracy
APT 0.890 ( 0.737 ~ 0.989 ) ≥ 1.53 86.4% 75.0% 82.4%
ADC 0.917 ( 0.786 ~ 0.984 ) < 1313.67 86.4% 75.0% 82.4%
rCBV 0.947 ( 0.810 ~ 1.000 ) ≥ 2.01 81.8% 91.7% 85.3%
a bias-corrected by bootstrapping with 1000 replications
Fig. 6. ROC curves of APT, ADC and rCBV for discriminating high grade 
from low grade gliomas.
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Fig. 7. Images obtained in a 52-year-old male with low grade glioma. (A) 
Postcontrast T1-weightedi image (B) T2-weighted image (C) ADC map (D) 
rCBV map (E) APT map 
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Fig. 8. Images obtained in a 76-year-old male with high grade glioma. (A) 
Postcontrast T1-weightedi image (B) T2-weighted image (C) ADC map (D) 
rCBV map (E) APT map 
5. Incremental diagnostic value of APT over ADC and rCBV for glioma 
grading
Incremental diagnostic value of APT over ADC and rCBV for glioma grading 
assessed by IDI are summarized in Table 5. Combination of APT and ADC 
values showed better diagnostic performance than ADC alone for glioma 
grading, with increased AUC from 0.917 to 0.955 and statistical significance. (p 
= 0.003) (Figure 8) In contrast to combination of APT and ADC, combination 
of APT and rCBV did not achieve significance improvement in glioma grading 
(p = 0.066), though accuracy was increased from 85.3% to 91.2%.
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Table 5. Incremental diagnostic values of APT SI over ADC and rCBV to 
discriminate high- and low-grade gliomas. (n=34)
AUC (95%CI) SensitivitySpecificityAccuracy IDI
Over ADC
ADC 0.917 (0.791 -0.977 ) 86.4% 75.0% 82.4% 0.177
(P = 
0.003)ADC + APT 0.955 (0.842 -1.000 ) 90.9% 91.7% 91.2%
Over rCBV
rCBV 0.947 (0.798 -1.000 ) 81.8% 91.7% 85.3% 0.096
(P = 
0.066)rCBV + APT0.947 (0.833 -0.993 ) 90.9% 91.7% 91.2%
Fig. 9. ROC curves of ADC alone and APT + ADC for discriminating high 
grade from low grade gliomas.
6. Correlation between APT SI and Ki-67 LI
Figure 9 shows correlation between APT SI and Ki-67 LI. High grade gliomas 
had significantly higher Ki-LI than low grade gliomas (3.6± 2.2 vs 23.5 ± 25.7, 
p = 0.012) . In linear regression, APT SI showed significant positive correlation 
with Ki-67 LI. (p=0.001, R2 = 0.26)
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Fig. 10. Scatterplot of APT SI and Ki-67 LI.
IV. DISCUSSION
We investigated the correlation between APT SI and glioma grades, compared 
the diagnostic value of APT with ADC and rCBV, and incremental value of 
APT over ADC and rCBV for discriminating between high and low grade 
gliomas with optimized APT imaging protocol. APT showed diagnostic value 
compatible with ADC and rCBV and had incremental value over ADC and 
rCBV for glioma grading, with higher APT SI in high grade than low grade 
gliomas. Also, we found positive correlation between APT SI and Ki-67 LI.
Advanced MRI techniques such as DWI or DSC MRI have been recently 
utilized as noninvasive biomarkers that correlated with histopathological grades 
and molecular or genectic profiles of glioma. 4–7,27 APT imaging, a subtype of 
CEST, can indirectly provide information about peptide or protein 
concentration within the tissue and has been investigated as an imaging 
biomarker in previous studies.12–16 Wen et al.18 analyzed 12 patients with high 
grade glioma, found that the average APT SI of the viable tumor cores and 
cystic cavities were significantly higher than those of peritumoral edema and 
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normal appearing white matter, and suggested that APT imaging at the protein 
and peptide level may enhance noninvasive identification of tissue 
heterogeneity in high grade brain tumors. Zhou et al 15 analyzed 6 rats with 
glioblastomas and radiation and suggested that viable glioma seen as 
hyperintense and and radiation necrosiss seen as hypointense to isointense could 
be clearly differentiated using APT MRI. Sagiyama et al 28 analyzed 9 mice 
with glioblastomas treated with temozolomide, found that the temozolomide-
resistant recurrent tumor showed higher APT SI than temozolomide-sensitive 
tumor before treatment and suggested the potential of APT imaging as a 
biomarker for early detection of treatment response in mouse using 7T MRI. 
Togao et al. 19 analyzed 37 human gliomas and found that the APT SI positively 
correlated with glioma grade, Ki-67 LI, and cell density with statistical 
significance. However, these previous studies have limited clinical feasibility, 
since APT imaging protocol was not optimized for clinical use, mouse models 
instead of human were scanned using experimental MRI with 4.7T or higher 
magnetic field, and human patients were scanned in only one representative 
slice of tumor. Herein, we optimized the APT imaging protocol using 3T MRI 
in clinic and validated APT imaging clinically in glioma patients.
In the phantom experiments for protocol optimization, APT SI values were 
higher in phantoms with higher BSA concentration and higher RF power and 
duration, whereas no significant difference was found in APT SI according to 
pH change. Since various factors including pH and asymmetric magnetization 
transfer from macromolecules, as well as protein concentration, can affect the 
APT SI, interpretation of APT SI of tumor is complicated. Lower APT SI 
values at 3.5ppm are theoretically expected in lower pH as proton exchange rate 
between amide and bulk water is slowed in lower pH, which is contrary to our 
results. However, previous studies that investigated the influence of pH on APT 
SI has found conflicting results. McVicar et al 29 reported that APT SI decreased 
with decreasing pH, whereas Jones et al. 30 reported that APT SI obtained from 
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3.3~3.7ppm showed fluctuated and various value with pH change. Interpretation 
of results from these previous and our studies needs caution due to 
heterogeneous sequence and RF power and duration of APT imaging protocol. 
Although signal from APT-weighted images mainly depended on protein 
concentration, not on pH, when using 3T MRI in clinic and GRASE sequence 
with RF frequency of 2 µT or above in our phantom experiments, underlying 
mechanism and exact contributors to APT SI still remains unclear.
ADC is considered as an index of cellularity and reflects tumor burden. 
Previous studies investigated the correlation of ADC with grade, molecular or 
genetic subclassification, or prognosis of glioma, but with conflicting results. 
4,8,9,27,31 rCBV reflects perfusion in tumor microenvironment, and high rCBV 
values have been known to be associated with high grade glioma and prognosis. 
5,7 While ADC does not require normalization to contralateral normal appearing 
white matter (NAWM), the voxel values on rCBV map reflects relative but not 
absolute cerebral blood volume, as implicated its name, so that rCBV requires 
normalization to contralateral normal appearing white matter in postprocessing. 
Prah et al 32 found that interobserver reliability of rCBV depends on the 
normalization or standardization methods, and within-subject coefficient of 
variation range 24%-67% for rCBV that is normalized to contralateral NAWM 
as in our study. In this study, rCBV showed the highest performance of glioma 
grading among APT, ADC and rCBV, and rCBV in combination with APT did 
not show significant improvement in diagnostic value compared to rCBV alone, 
in contrast to ADC with which APT imaging has incremental diagnostic value 
for glioma grading. These results should be interpreted cautiously considering 
variability of rCBV. It is possible that APT can have significant incremental 
value over rCBV depending on normalization, considering that reclassification 
by APT over rCBV was of borderline significance (p=0.066), although only 95% 
CI but not AUC changed in our results. The opposite is also possible for ADC, 
considering interobserver variability of ADC that depends on ROI selection. 
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Although no normalization is required for ADC postprocessing, Ahn et al 33
found that interobserver variability of ADC changed according to ROI selection, 
and selection of multiple hot spot ROIs as in our study showed higher 
interoberver variability than selection of entire tumor for ROIs. Thus, further 
investigations using rCBV standardization and ROI selection with high 
interoberver reliability are necessary. 
There were several limitations in our study, aside from retrospective manner. 
First, only small number of patients (n=39) were enrolled and 3 among them 
were unavailable for preoperative DWI and DSC MRI. Second, locus-specific 
correlations of APT SI to WHO grades and Ki-67 LI were not conducted. 
Glioma grade and Ki-67 LI may be heterogeneous considering previously 
reported ntratumoral heterogeneity, especially in high grade glioma, and the 
ROIs on APT-wegihted images may have different glioma grades and Ki-67 LI 
from those in the pathological report. Third, hot spot method placing several 
circular ROIs on the high APT and rCBV, and low ADC values were used 
instead of segmenting the entire enhancing tumor. Although Ahn et al. 33
suggested that hot spot method has higher interobserver variability than 
segmenting the entire tumor, Sakata et al.34  reported that no significant 
difference in glioma grading ability was found among variable ROI selections 
on APT images, including placing ROIs on a single representative slice and all 
slices of whole tumor, and with and without normalization to contralateral 
NAWM. We used several circular ROIs without normalization for APT SI 
based on the previous study by Sakata et al., and used the same ROI selection 
for ADC and rCBV to compare the diagnostic value for discriminating high 
grade from low grade gliomas. In our opinion, although a ROI selection with 
higher interoberver reliability, such as semiautomatic segmentation of the entire 
enhancing tumor, have been better for more accurate comparison between APT, 
ADC, and rCBV, the resolution of APT imaging needs to be improved for fair 
coresgitration with postcontrast T1-weighted images.
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V. CONCLUSION
APT SI showed diagnostic value for glioma grading compatible for those of 
ADC and rCBV. APT imaging had significant incremental value over ADC, but 
not over rCBV for discriminating high grade from low grade gliomas. APT SI 
was positively correlated with Ki-67 index. Also, we experimentally confirmed 
that APT SI correlated more with protein concentration than pH. Our results 
suggests the potential of APT imaging as a useful noninvasive imaging 
biomarker of glioma, including decisions for surgical sampling sites and 
therapeutic strategy. 
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ABSTRACT(IN KOREAN)
성인 Diffuse glioma 의 조직병리학적 등급 평가에 대한 Amide 
proton transfer imaging 의 가치 : Dynamic susceptibility contrast-
enhanced MRI 및 Diffusion weighted imaging 과의 비교 및 이에
대한 추가적 가치
<지도교수 이승구>
연세대학교 대학원 의학과
최윤성
목적 : Amide proton transfer (APT) 은 chemical exchange saturation transfer 
의 한 종류로서 조영제 주입 없이  peptide 및 protein 농도를
반영하는 새로운 기법이다. 이 연구에서는 APT value가 성인 diffuse 
glioma의 조직병리학적 등급에 따라 어떻게 변하는지 알아보고, 
더불어 조직병리학적 등급에 대한 APT value의 진단적 가치를
dynamic susceptibility contrast-enhanced (DSC) MRI의 relative cerebral blood 
volume (rCBV) 및 diffusion weighted imaging (DWI)의 apparent diffusion 
coefficient (ADC)의 그것과 비교하고, 더불어 rCBV 혹은 ADC에 더한
APT value의 추가적 진단적 가치를 고찰하였다.
재료 및 방법: 이 연구는 수술 전 APT weighted imaging 을 시행한  
39명의 조직병리학적으로 확인된 diffuse glioma 환자를 대상으로
하였으며, 이중 23명은 수술 전 DSC MRI와 DWI를 시행하였다. 
Regions of interest 는 APT, rCBV map 에서의 높은 signal 부위, 그리고
ADC map의 낮은 signal 부위에 수동으로 지정하였다. APT signal은
WHO grade 혹은 low vs high grade glioma 에 따라 비교하였다. Receiver 
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operative characteristic (ROC) analysis를 이용하여, APT value의 Low 
grade와 high grade를 구분하는 진단적 가치를 ADC 및 rCBV의 그것과
비교하였고, integrated discrimination index를 이용하여 ADC 혹은
rCBV에 더한 APT value의 추가적 진단적 가치를 분석하였다. 또한, 
APT value와 Ki-67 labeling index (LI)와의 관계를 linear regression으로
분석하였다.
결과: APT SI는 grade II glioma는 0.82 ± 0.36%, grade III에서는 1.73 ± 
0.86%, grade IV 에서는 2.62 ± 0.78% 로 각 grade 별로 유의미한
차이가 있었다. (p < 0.05 for all comparisons) Low grade 와 high grade 
glioma를 구분하는 진단적 능력은 APT SI, ADC, rCBV사이에 유의미한
차이가 없었으며, area under ROC curve (AUC)값은 APT 는 0.890, 
ADC는 0.917, rCBV는 0.947 이었다. APT 의 추가적 진단적 가치는
ADC에 더하였을 때 유의미하였으며 (p=0.033), rCBV에 대해서는
통계적으로 유의미하지 않았다(p=0.066). APT SI는 Ki-67과 유의미한
상관관계를 보였다 (p=0.001, R2 = 0.26). 
결론: APT imaging은 성인의 low grade glioma와 high grade glioma의
구분에 있어 유용하며, 기존의 ADC에 대해 추가적 진단적 가치를
가지고, 또한 APT SI는 Ki-67과 유의미한 상관관계를 가지는 것으로
사료된다. 
---------------------------------------------------------------------------------------
핵심되는 말 : 뇌교종, 등급, 자기공명영상, amide proton transfer, 
chemical exchange saturation transfer 
